Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/2253196

Cancer Res. 1990 Dec 1 50 23 7490-5

Download in:

View as

Triples

General Info

PMID
2253196